Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells

Neuroblastoma is the most commonly diagnosed extracranial tumor in the first year of life. Approximately 9% of neuroblastoma patients present germline or somatic aberrations in the gene encoding for anaplastic lymphoma kinase (ALK). This increases in high-risk neuroblastomas, which have a 14% freque...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervantes-Madrid, Diana, Szydzik, Joanna, Lind, Dan Emil, Borenäs, Marcus, Bemark, Mats, Cui, Jean, Palmer, Ruth Helen, Hallberg, Bengt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920469/
https://www.ncbi.nlm.nih.gov/pubmed/31852910
http://dx.doi.org/10.1038/s41598-019-55060-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920469/
https://www.ncbi.nlm.nih.gov/pubmed/31852910
http://dx.doi.org/10.1038/s41598-019-55060-7

Ejemplares similares